Boston Scientific (BSX)

EBITDA Growth

23.15%

TTM · Period ending:

BSX logo

BSX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported23.15%
BSX TTM EBITDA YoY % (38.10% → 23.15%)
High-resolution chart · PNG

BSX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Boston Scientific EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-22.4396%
-10.8744%
-6.0373%
647.5329%
738.8031%
4,947.8261%
804.0185%
-69.2619%
-73.4427%
-104.4563%
-131.2033%
-0.7277%
1.8272%
-0.6975%
-12.7131%
-21.8168%
-20.0709%
8.564%
66.6433%
91.6886%
118.8584%
119.4842%
119.3077%
110.8644%
78.4841%
45.903%
13.1419%
17.0845%
16.9685%
19.005%
17.8462%
532.5301%
1,015.9574%
138.7173%
38.102%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.